Jennifer Cox
Pediatric Hematology-Oncology · Huntsville, ALNPI 1669560827
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $950, 4.1 times the $231 reported in 2019.
Across 85 payments — averaging $30.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$387
- Novo Nordisk$373
- Springworks Therapeutics, Inc.$183
- Servier Pharmaceuticals LLC$164
- Sobi, Inc$157
- Agios Pharmaceuticals, Inc.$146
- plus $1K from 23 others
Across 6 payments — averaging $88,037 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seagen Inc.$408K
- Amgen$74K
- E.r. Squibb & Sons, L.L.C.$46K
What the payments were for
- Food & beverage$2,616100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 7 | $387 |
| Novo Nordisk | 12 | $373 |
| Springworks Therapeutics, Inc. | 8 | $183 |
| Servier Pharmaceuticals LLC | 4 | $164 |
| Sobi, Inc | 4 | $157 |
| Agios Pharmaceuticals, Inc. | 2 | $146 |
| Sanofi-aventis U.S. LLC | 3 | $124 |
| Incyte Corporation | 1 | $124 |
| Merck | 6 | $119 |
| Pfizer | 4 | $95 |
| Novartis | 2 | $80 |
| AstraZeneca | 4 | $79 |
| Johnson & Johnson(2 entities) | 4 | $69 |
| RARE Disease Therapeutics, Inc. | 3 | $67 |
| Global Blood Therapeutics, Inc. | 4 | $62 |
| CSL Behring | 2 | $59 |
| Y-mabs Therapeutics, Inc. | 2 | $44 |
| Bayer | 2 | $42 |
| Adaptive Biotechnologies Corporation | 1 | $35 |
| Teleflex LLC | 1 | $26 |
| Syndax Pharmaceuticals, Inc. | 1 | $24 |
| HEMA Biologics, LLC | 1 | $23 |
| Mesoblast, Inc. | 1 | $23 |
| Bristol Myers Squibb | 1 | $21 |
| Emmaus Medical, Inc. | 1 | $21 |
| USWM, LLC | 1 | $19 |
| Abbott | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,616 in reported general payments places this provider in the 75th percentile of 38 pediatric hematology-oncology providers in Alabama.
See all pediatric hematology-oncology providers in Alabama →
Other pediatric hematology-oncology in Huntsville
- Gail Cranshaw MegasonHuntsville$13K
- Marla DavesHuntsville$1K
- Jamie MusickHuntsville$648
- Sana MohiuddinHuntsville$467
- Carolyn RussoHuntsville$22
- Julie Kanter WashkoBirmingham$273K
- Aman WadhwaBirmingham$100K
- Frederick GoldmanBirmingham$76K
- Felicia WilsonMobile$65K
- Jeffrey LebensburgerBirmingham$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.